Andris D A, Krzywda E A, Edmiston C E, Krepel C J, Gohr C M
Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.
Nutrition. 1998 May;14(5):427-32. doi: 10.1016/s0899-9007(98)00013-6.
An in vitro model was designed to evaluate the efficacy of instilled antimicrobials to reduce or eliminate intraluminal microbial colonization. Minimal inhibitory concentration and minimal bactericidal concentration activity of appropriate test anti-infectives were determined using standard methodology against clinically derived and reference test strains commonly associated with catheter-related infection. Drug activity was validated by bioassay for the test anti-infectives. Reference and clinical test strains were inoculated to the intraluminal surface of silicone catheter segments and incubated for 30 min, after which the inoculum was replaced with total parenteral nutrition (TPN) solution and reincubated for 12 h. For 7 d, instillation of antibiotic and TPN solution was alternated every 12 h to simulate clinical conditions. On days 1, 4, and 7, catheter segments were rinsed, bisected, and sonicated for quantitative plate count to determine mean microbial counts per centimeter of catheter surface. Catheter segments were also prepared for scanning electron microscopy. A significant decrease in staphylococcal intraluminal colonization after instillation of nafcillin, ceftriaxone, gentamicin, and vancomycin was demonstrated (P < 0.001). Aztreonam, ceftriaxone, and gentamicin completely eliminated gram-negative catheter colonization (P < 0.001). Yeast was eradicated from the internal catheter surface after treatment with amphoteracin B, and fluconazole significantly decreased intraluminal colonization (P < 0.001). Results show a significant decrease in staphylococcal, gram-negative, and fungal intraluminal colonization after instillation of appropriate antimicrobial. In vitro results support early clinical success using this technique. Future studies are warranted to identify optimal drug concentrations and dosing intervals.
设计了一种体外模型,以评估注入抗菌药物减少或消除管腔内微生物定植的效果。使用标准方法针对与导管相关感染常见的临床分离菌株和参考测试菌株,测定了合适的测试抗感染药物的最低抑菌浓度和最低杀菌浓度活性。通过生物测定法验证了测试抗感染药物的活性。将参考菌株和临床测试菌株接种到硅胶导管段的管腔内表面,孵育30分钟,之后用全胃肠外营养(TPN)溶液替换接种物,并再孵育12小时。连续7天,每12小时交替注入抗生素和TPN溶液,以模拟临床情况。在第1、4和7天,冲洗导管段,将其对半切开,并进行超声处理以进行定量平板计数,以确定每厘米导管表面的平均微生物计数。还制备了导管段用于扫描电子显微镜检查。结果表明,注入萘夫西林、头孢曲松、庆大霉素和万古霉素后,葡萄球菌在管腔内的定植显著减少(P < 0.001)。氨曲南、头孢曲松和庆大霉素完全消除了革兰氏阴性菌在导管内的定植(P < 0.001)。用两性霉素B治疗后,酵母从导管内表面被根除,氟康唑显著减少了管腔内的定植(P < 0.001)。结果显示,注入合适的抗菌药物后,葡萄球菌、革兰氏阴性菌和真菌在管腔内的定植显著减少。体外研究结果支持该技术早期在临床上取得成功。有必要进行进一步的研究以确定最佳药物浓度和给药间隔。